vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Whitestone REIT (WSR). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $43.9M, roughly 1.9× Whitestone REIT). Whitestone REIT runs the higher net margin — 52.0% vs 22.8%, a 29.2% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 7.5%). Whitestone REIT produced more free cash flow last quarter ($50.5M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 8.7%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Whitestone REIT is a publicly traded real estate investment trust that acquires, owns, manages and redevelops open-air community shopping centers, primarily located in high-growth metropolitan areas across the southwestern and southeastern United States. Its property portfolio is largely anchored by daily necessity, service-focused retail tenants that cater to regular local consumer demand.
FDMT vs WSR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $43.9M |
| Net Profit | $19.4M | $22.8M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | 53.0% |
| Net Margin | 22.8% | 52.0% |
| Revenue YoY | 8508900.0% | 7.5% |
| Net Profit YoY | 139.1% | 31.7% |
| EPS (diluted) | $0.43 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $43.9M | ||
| Q3 25 | $90.0K | $41.0M | ||
| Q2 25 | $15.0K | $37.9M | ||
| Q1 25 | $14.0K | $38.0M | ||
| Q4 24 | $1.0K | $40.8M | ||
| Q3 24 | $3.0K | $38.6M | ||
| Q2 24 | $5.0K | $37.6M | ||
| Q1 24 | $28.0K | $37.2M |
| Q4 25 | $19.4M | $22.8M | ||
| Q3 25 | $-56.9M | $18.3M | ||
| Q2 25 | $-54.7M | $5.1M | ||
| Q1 25 | $-48.0M | $3.7M | ||
| Q4 24 | — | $17.3M | ||
| Q3 24 | $-43.8M | $7.6M | ||
| Q2 24 | $-35.0M | $2.6M | ||
| Q1 24 | $-32.4M | $9.3M |
| Q4 25 | 17.3% | 53.0% | ||
| Q3 25 | -67983.3% | 45.5% | ||
| Q2 25 | -396373.3% | 13.8% | ||
| Q1 25 | -383007.1% | 10.2% | ||
| Q4 24 | — | 43.3% | ||
| Q3 24 | -1704400.0% | 20.3% | ||
| Q2 24 | -849120.0% | 7.2% | ||
| Q1 24 | -136200.0% | 25.9% |
| Q4 25 | 22.8% | 52.0% | ||
| Q3 25 | -63195.6% | 44.7% | ||
| Q2 25 | -364386.7% | 13.3% | ||
| Q1 25 | -342657.1% | 9.7% | ||
| Q4 24 | — | 42.5% | ||
| Q3 24 | -1461433.3% | 19.7% | ||
| Q2 24 | -699060.0% | 6.9% | ||
| Q1 24 | -115717.9% | 25.1% |
| Q4 25 | $0.43 | $0.43 | ||
| Q3 25 | $-1.01 | $0.35 | ||
| Q2 25 | $-0.98 | $0.10 | ||
| Q1 25 | $-0.86 | $0.07 | ||
| Q4 24 | — | $0.34 | ||
| Q3 24 | $-0.79 | $0.15 | ||
| Q2 24 | $-0.63 | $0.05 | ||
| Q1 24 | $-0.66 | $0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $4.9M |
| Total DebtLower is stronger | — | $649.4M |
| Stockholders' EquityBook value | $505.7M | $458.1M |
| Total Assets | $566.7M | $1.2B |
| Debt / EquityLower = less leverage | — | 1.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $4.9M | ||
| Q3 25 | $305.1M | $6.8M | ||
| Q2 25 | $293.2M | $5.3M | ||
| Q1 25 | $321.4M | $5.6M | ||
| Q4 24 | $424.9M | $5.2M | ||
| Q3 24 | $501.9M | $2.5M | ||
| Q2 24 | $541.9M | $3.2M | ||
| Q1 24 | $525.9M | $6.2M |
| Q4 25 | — | $649.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $632.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $505.7M | $458.1M | ||
| Q3 25 | $369.0M | $439.5M | ||
| Q2 25 | $420.9M | $427.5M | ||
| Q1 25 | $469.7M | $431.0M | ||
| Q4 24 | $510.6M | $438.2M | ||
| Q3 24 | $552.9M | $419.5M | ||
| Q2 24 | $588.3M | $418.3M | ||
| Q1 24 | $600.6M | $421.6M |
| Q4 25 | $566.7M | $1.2B | ||
| Q3 25 | $424.0M | $1.1B | ||
| Q2 25 | $473.6M | $1.2B | ||
| Q1 25 | $515.7M | $1.1B | ||
| Q4 24 | $560.4M | $1.1B | ||
| Q3 24 | $604.0M | $1.1B | ||
| Q2 24 | $620.1M | $1.1B | ||
| Q1 24 | $629.9M | $1.1B |
| Q4 25 | — | 1.42× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.44× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $50.8M |
| Free Cash FlowOCF − Capex | $28.5M | $50.5M |
| FCF MarginFCF / Revenue | 33.5% | 114.9% |
| Capex IntensityCapex / Revenue | 0.1% | 0.7% |
| Cash ConversionOCF / Net Profit | 1.47× | 2.22× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $50.8M | ||
| Q3 25 | $-46.5M | $18.0M | ||
| Q2 25 | $-43.4M | $13.8M | ||
| Q1 25 | $-47.8M | $3.1M | ||
| Q4 24 | $-134.6M | $58.2M | ||
| Q3 24 | $-29.4M | $16.4M | ||
| Q2 24 | $-30.2M | $12.3M | ||
| Q1 24 | $-29.1M | $11.5M |
| Q4 25 | $28.5M | $50.5M | ||
| Q3 25 | $-46.6M | — | ||
| Q2 25 | $-43.4M | — | ||
| Q1 25 | $-48.4M | — | ||
| Q4 24 | $-138.4M | $58.0M | ||
| Q3 24 | $-31.2M | — | ||
| Q2 24 | $-30.6M | — | ||
| Q1 24 | $-29.8M | — |
| Q4 25 | 33.5% | 114.9% | ||
| Q3 25 | -51765.6% | — | ||
| Q2 25 | -289620.0% | — | ||
| Q1 25 | -345635.7% | — | ||
| Q4 24 | -13837100.0% | 142.1% | ||
| Q3 24 | -1038966.7% | — | ||
| Q2 24 | -611840.0% | — | ||
| Q1 24 | -106421.4% | — |
| Q4 25 | 0.1% | 0.7% | ||
| Q3 25 | 101.1% | — | ||
| Q2 25 | 440.0% | — | ||
| Q1 25 | 4507.1% | — | ||
| Q4 24 | 378600.0% | 0.5% | ||
| Q3 24 | 59266.7% | — | ||
| Q2 24 | 6980.0% | — | ||
| Q1 24 | 2535.7% | — |
| Q4 25 | 1.47× | 2.22× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 2.74× | ||
| Q1 25 | — | 0.83× | ||
| Q4 24 | — | 3.36× | ||
| Q3 24 | — | 2.15× | ||
| Q2 24 | — | 4.73× | ||
| Q1 24 | — | 1.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
